Rechercher
Journal Club: LUBAC accelerates B-cell lymphomagenesis by conferring B cells resistance to genotoxic
- Blood 2020
- 2 juin 2020
- 1 min de lecture
Key Points
LUBAC accelerates B-cell lymphomagenesis through protection of DNA damage-induced apoptosis, thereby promoting AID-mediated mutations.
Inhibition of LUBAC by small molecules is a promising therapeutic strategy for B-cell lymphomas with NF-kB activation.
Posts récents
Voir toutNature Cell Biology 2025 Abstract Cells secrete a large variety of extracellular vesicles (EVs) to engage in cell-to-cell and...